Cannabis Bioscience International Holdings, Inc. reported earnings results for the full year ended May 31, 2023. For the full year, the company reported sales was USD 0.316825 million compared to USD 0.21498 million a year ago. Net loss was USD 1.03 million compared to USD 0.885171 million a year ago.

Basic loss per share from continuing operations was USD 0.00011 compared to USD 0.00011 a year ago.